What is pygeum?
Pygeum refers to extracts from the bark of Prunus africana, an African tree historically used for urinary and prostate complaints. Modern prostate supplements may still include pygeum, although it is less ubiquitous than saw palmetto.
What does the clinical evidence show?
A systematic review and quantitative meta-analysis of randomized trials found that pygeum preparations were associated with improvement in BPH-related urinary outcomes compared with placebo. A Cochrane review included 18 randomized controlled trials with 1,562 men and concluded that standardized pygeum may be a useful option for lower urinary symptoms consistent with BPH.
Why the evidence is still described as limited
The core trials were generally small and short, and they used varied doses and preparations. NCCIH therefore describes the evidence as limited despite the positive signal. This is a good example of the difference between “some evidence of benefit” and “strong modern evidence.”
What outcomes were studied?
Research has examined symptom measures, urinary flow, nocturia and other lower urinary tract outcomes. Those findings should not be expanded into claims that pygeum prevents prostate cancer, permanently reverses BPH or guarantees improved sexual performance.
Preparation and sourcing matter
Pygeum is a botanical extract, so extraction method and dose affect comparability with research. There is also a sustainability dimension because Prunus africana is a harvested tree species with conservation concerns in parts of its range. A high-quality product should identify the botanical clearly and use responsible sourcing where possible.
Safety
NCCIH reports that pygeum was generally well tolerated in clinical research, with mild adverse effects such as nausea, diarrhea, constipation and headache. As with other botanicals, users taking medicines or multiple supplements should review the complete combination rather than assume the historical use means there are no interactions.
Pygeum versus beta-sitosterol and nettle
All three ingredients have human evidence relevant to BPH-associated urinary symptoms, but much of the classic evidence is older. Beta-sitosterol has systematic-review evidence for symptom and flow improvement without prostate-size reduction. Nettle has a notable large randomized trial. Pygeum has a broader group of older trials but substantial heterogeneity.
How to judge a product containing pygeum
- Check the amount and extract details.
- Look for transparent botanical naming.
- Do not rely on a proprietary blend that hides the pygeum amount.
- Check whether the claimed outcome matches the research endpoint.
- Use a broader medical assessment when symptoms are persistent or severe.
Bottom line
Pygeum is a legitimate evidence-relevant ingredient in the prostate-supplement category, but its strongest clinical evidence is old, heterogeneous and short-term. It is best treated as an ingredient with a positive historical signal that still needs better modern replication—not as a proven treatment.